Component
Hypochlorous acid / HOCl
Hypochlorous acid / HOCl. Species, exposure and limitations are retained in each linked claim.
7 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
Myeloperoxidase used hydrogen peroxide to oxidize chloride to hypochlorous acid.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/chloride-research/9359420.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "83dc6a264dfb45201104568ac58c76509aaa0fabca1f32efd25861146b4b38c0", "start_char": 0, "end_char": 1700, "text_sha256": "83dc6a264dfb45201104568ac58c76509aaa0fabca1f32efd25861146b4b38c0"}
- experimental_model
- Purified-enzyme substrate kinetics
- exposure
- 100 mM chloride with varying thiocyanate
- limitations
- Product chemistry under assay conditions; not a recommendation to raise chloride or thiocyanate intake.
- nutrient_topic
- Chloride research collection; topical membership is not evidence of a direct dietary effect. · Chloride
- organism
- Human neutrophil enzyme
- plain_language
- Immune chemistry can convert chloride into a reactive antimicrobial oxidant.
- primary_references
- [chloride-p9359420] Thiocyanate and chloride as competing substrates for myeloperoxidase. (1997). https://pubmed.ncbi.nlm.nih.gov/9359420/ DOI: 10.1042/bj3270487
- tissue_or_cell_type
- Myeloperoxidase reaction mixture
Chloride: transport, acid-base balance, nutrient interactions and loss states (2026-09-17) · lines 614–625
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified-enzyme substrate kinetics · source_derived_draft · unverified_draft
### chloride-mpo-hocl Myeloperoxidase used hydrogen peroxide to oxidize chloride to hypochlorous acid. Condition category: normal nutrient_topic: Chloride research collection; topical membership is not evidence of a direct dietary effect. plain_language: Immune chemistry can convert chloride into a reactive antimicrobial oxidant. organism: Human neutrophil enzyme tissue_or_cell_type: Myeloperoxidase reaction mixture experimental_model: Purified-enzyme substrate kinetics limitations: Product chemistry under assay conditions; not a recommendation to raise chloride or thiocyanate intake. exposure: 100 mM chloride with varying thiocyanate evidence_span: {"source_cache": "artifacts/chloride-research/9359420.abstract.txt", "locator": "Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "83dc6a264dfb45201104568ac58c76509aaa0fabca1f32efd25861146b4b38c0", "start_char": 0, "end_char": 1700, "text_sha256": "83dc6a264dfb45201104568ac58c76509aaa0fabca1f32efd25861146b4b38c0"} [chloride-p9359420] Thiocyanate and chloride as competing substrates for myeloperoxidase. (1997). https://pubmed.ncbi.nlm.nih.gov/9359420/ DOI: 10.1042/bj3270487
Complete structured claim and evidenceBetanin reacted directly with hypochlorous acid in the kinetic assay.
Experimental context and source evidence
- dose
- Micromolar substrates; concentration-dependent chlorination assays
- duration
- Rapid kinetic measurements at 25 degrees C; pH 7.0 and pH 5.0
- evidence_access
- Primary PubMed abstract; detailed exposure for PMID 23931157 additionally checked in publisher results. No uninspected full text is claimed.
- evidence_scope
- literature_reviewed; source-derived curation, not universally established human effects
- experimental_model
- Purified human myeloperoxidase; cell-free chemistry
- limitations
- MPO substrates can stimulate or inhibit chlorination depending on conditions; not a universal MPO inhibitor.
- nutrient_topic
- Betalains collection; each molecular form, species, exposure and preparation remains explicit. · Betalains
- organism
- Purified human myeloperoxidase; cell-free chemistry
- plain_language
- Betanin reacted directly with hypochlorous acid in the kinetic assay.
- primary_references
- Mechanism of interaction of betanin and indicaxanthin with human myeloperoxidase and hypochlorous acid. (2005). https://pubmed.ncbi.nlm.nih.gov/15913556/ DOI: 10.1016/j.bbrc.2005.05.031
- route
- In vitro reagent addition
- tissue
- MPO redox cycle and HOCl solution
Betalains: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 127–135
Original AI-assisted curation of twelve primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Purified human myeloperoxidase; cell-free chemistry · source_derived_draft · unverified_draft
## betalains-betanin-hocl Betanin reacted directly with hypochlorous acid in the kinetic assay. Model/species: Purified human myeloperoxidase; cell-free chemistry Tissue: MPO redox cycle and HOCl solution Exposure: Micromolar substrates; concentration-dependent chlorination assays Route: In vitro reagent addition Duration: Rapid kinetic measurements at 25 degrees C; pH 7.0 and pH 5.0 Limits: MPO substrates can stimulate or inhibit chlorination depending on conditions; not a universal MPO inhibitor. Primary reference: Mechanism of interaction of betanin and indicaxanthin with human myeloperoxidase and hypochlorous acid. (2005). https://pubmed.ncbi.nlm.nih.gov/15913556/ DOI: 10.1016/j.bbrc.2005.05.031
Complete structured claim and evidenceIndicaxanthin reacted directly with hypochlorous acid in the kinetic assay.
Experimental context and source evidence
- dose
- Micromolar substrates; concentration-dependent chlorination assays
- duration
- Rapid kinetic measurements at 25 degrees C; pH 7.0 and pH 5.0
- evidence_access
- Primary PubMed abstract; detailed exposure for PMID 23931157 additionally checked in publisher results. No uninspected full text is claimed.
- evidence_scope
- literature_reviewed; source-derived curation, not universally established human effects
- experimental_model
- Purified human myeloperoxidase; cell-free chemistry
- limitations
- MPO substrates can stimulate or inhibit chlorination depending on conditions; not a universal MPO inhibitor.
- nutrient_topic
- Betalains collection; each molecular form, species, exposure and preparation remains explicit. · Betalains
- organism
- Purified human myeloperoxidase; cell-free chemistry
- plain_language
- Indicaxanthin reacted directly with hypochlorous acid in the kinetic assay.
- primary_references
- Mechanism of interaction of betanin and indicaxanthin with human myeloperoxidase and hypochlorous acid. (2005). https://pubmed.ncbi.nlm.nih.gov/15913556/ DOI: 10.1016/j.bbrc.2005.05.031
- route
- In vitro reagent addition
- tissue
- MPO redox cycle and HOCl solution
Betalains: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 167–175
Original AI-assisted curation of twelve primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Purified human myeloperoxidase; cell-free chemistry · source_derived_draft · unverified_draft
## betalains-indicaxanthin-hocl Indicaxanthin reacted directly with hypochlorous acid in the kinetic assay. Model/species: Purified human myeloperoxidase; cell-free chemistry Tissue: MPO redox cycle and HOCl solution Exposure: Micromolar substrates; concentration-dependent chlorination assays Route: In vitro reagent addition Duration: Rapid kinetic measurements at 25 degrees C; pH 7.0 and pH 5.0 Limits: MPO substrates can stimulate or inhibit chlorination depending on conditions; not a universal MPO inhibitor. Primary reference: Mechanism of interaction of betanin and indicaxanthin with human myeloperoxidase and hypochlorous acid. (2005). https://pubmed.ncbi.nlm.nih.gov/15913556/ DOI: 10.1016/j.bbrc.2005.05.031
Complete structured claim and evidenceSAC scavenged hypochlorous acid / hocl in the tested chemical system; IC50 was 2.86 mM.
Experimental context and source evidence
- acting_entity
- s-allylcysteine
- dose
- Assay-specific millimolar IC50 values
- duration
- Not specified in accessed abstract
- evidence_access
- Primary abstract
- experimental_comparison
- SAC concentration series versus corresponding reference scavengers
- experimental_model
- Reactive-species scavenging systems
- interpretation_status
- Source-derived research curation; not independent primary verification
- limitations
- Assay potency is not an achieved human tissue concentration.
- nutrient_topic
- S-allylcysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · S-allyl-L-cysteine / SAC
- organism
- Cell-free chemical assays
- plain_language
- Direct chemistry has a measured concentration requirement.
- primary_references
- [17576034] S-allylcysteine scavenges singlet oxygen and hypochlorous acid and protects LLC-PK(1) cells of potassium dichromate-induced toxicity. · 2007 · https://pubmed.ncbi.nlm.nih.gov/17576034/ · DOI 10.1016/j.fct.2007.05.002
- route
- In vitro
- tissue_or_cell_type
- Reactive-species scavenging systems
S-allylcysteine: sulfur signaling, redox responses and cross-nutrient mechanisms (2026-09-20) · lines 95–102
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Reactive-species scavenging systems · source_derived_draft · unverified_draft
## s-allylcysteine-scavenging-hocl Direct chemistry has a measured concentration requirement. SAC scavenged hypochlorous acid / hocl in the tested chemical system; IC50 was 2.86 mM. Model: Reactive-species scavenging systems Limitations: Assay potency is not an achieved human tissue concentration. Evidence access: Primary abstract [17576034] S-allylcysteine scavenges singlet oxygen and hypochlorous acid and protects LLC-PK(1) cells of potassium dichromate-induced toxicity. · 2007 · https://pubmed.ncbi.nlm.nih.gov/17576034/ · DOI 10.1016/j.fct.2007.05.002 Structured context: {"organism": "Cell-free chemical assays", "tissue_or_cell_type": "Reactive-species scavenging systems", "dose": "Assay-specific millimolar IC50 values", "duration": "Not specified in accessed abstract", "route": "In vitro", "experimental_comparison": "SAC concentration series versus corresponding reference scavengers", "acting_entity": "s-allylcysteine", "interpretation_status": "Source-derived research curation; not independent primary verification"}
Complete structured claim and evidence
Where it participates (unsigned role)
Purified myeloperoxidase plus hydrogen peroxide, chloride and taurine generated taurine chloramine; removing chloride or peroxide, or inhibiting MPO, blocked generation.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Purified human MPO system and stimulated human neutrophils.
- limitations
- Taurine chloramine remains an oxidant; free taurine is not equivalent to every chloramine effect.
- nutrient_topic
- Taurine collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Taurine
- plain_language
- An immune-cell oxidant reacts with taurine to make a different active molecule.
- primary_references
- Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. · 1982 · https://pubmed.ncbi.nlm.nih.gov/6286728/ · DOI 10.1172/jci110652
Taurine: synthesis, transport, mitochondrial decoding and nutrient interactions (2026-09-19) · lines 361–367
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Purified human MPO system and stimulated human neutrophils. · source_derived_draft · unverified_draft
## taurine-mpo-chlorination An immune-cell oxidant reacts with taurine to make a different active molecule. Purified myeloperoxidase plus hydrogen peroxide, chloride and taurine generated taurine chloramine; removing chloride or peroxide, or inhibiting MPO, blocked generation. Model: Purified human MPO system and stimulated human neutrophils. Limitations: Taurine chloramine remains an oxidant; free taurine is not equivalent to every chloramine effect. Evidence access: Primary abstract Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. · 1982 · https://pubmed.ncbi.nlm.nih.gov/6286728/ · DOI 10.1172/jci110652
Complete structured claim and evidenceBetanin stimulated or inhibited MPO chlorination at neutral pH depending on concentration; at pH 5 only inhibition was observed.
Experimental context and source evidence
- dose
- Micromolar substrates; concentration-dependent chlorination assays
- duration
- Rapid kinetic measurements at 25 degrees C; pH 7.0 and pH 5.0
- evidence_access
- Primary PubMed abstract; detailed exposure for PMID 23931157 additionally checked in publisher results. No uninspected full text is claimed.
- evidence_scope
- literature_reviewed; source-derived curation, not universally established human effects
- experimental_model
- Purified human myeloperoxidase; cell-free chemistry
- limitations
- MPO substrates can stimulate or inhibit chlorination depending on conditions; not a universal MPO inhibitor.
- nutrient_topic
- Betalains collection; each molecular form, species, exposure and preparation remains explicit. · Betalains
- organism
- Purified human myeloperoxidase; cell-free chemistry
- plain_language
- Betanin stimulated or inhibited MPO chlorination at neutral pH depending on concentration; at pH 5 only inhibition was observed.
- primary_references
- Mechanism of interaction of betanin and indicaxanthin with human myeloperoxidase and hypochlorous acid. (2005). https://pubmed.ncbi.nlm.nih.gov/15913556/ DOI: 10.1016/j.bbrc.2005.05.031
- route
- In vitro reagent addition
- tissue
- MPO redox cycle and HOCl solution
Betalains: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 137–145
Original AI-assisted curation of twelve primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Purified human myeloperoxidase; cell-free chemistry · source_derived_draft · unverified_draft
## betalains-betanin-chlorination Betanin stimulated or inhibited MPO chlorination at neutral pH depending on concentration; at pH 5 only inhibition was observed. Model/species: Purified human myeloperoxidase; cell-free chemistry Tissue: MPO redox cycle and HOCl solution Exposure: Micromolar substrates; concentration-dependent chlorination assays Route: In vitro reagent addition Duration: Rapid kinetic measurements at 25 degrees C; pH 7.0 and pH 5.0 Limits: MPO substrates can stimulate or inhibit chlorination depending on conditions; not a universal MPO inhibitor. Primary reference: Mechanism of interaction of betanin and indicaxanthin with human myeloperoxidase and hypochlorous acid. (2005). https://pubmed.ncbi.nlm.nih.gov/15913556/ DOI: 10.1016/j.bbrc.2005.05.031
Complete structured claim and evidenceIndicaxanthin stimulated or inhibited MPO chlorination at neutral pH depending on concentration; at pH 5 only inhibition was observed.
Experimental context and source evidence
- dose
- Micromolar substrates; concentration-dependent chlorination assays
- duration
- Rapid kinetic measurements at 25 degrees C; pH 7.0 and pH 5.0
- evidence_access
- Primary PubMed abstract; detailed exposure for PMID 23931157 additionally checked in publisher results. No uninspected full text is claimed.
- evidence_scope
- literature_reviewed; source-derived curation, not universally established human effects
- experimental_model
- Purified human myeloperoxidase; cell-free chemistry
- limitations
- MPO substrates can stimulate or inhibit chlorination depending on conditions; not a universal MPO inhibitor.
- nutrient_topic
- Betalains collection; each molecular form, species, exposure and preparation remains explicit. · Betalains
- organism
- Purified human myeloperoxidase; cell-free chemistry
- plain_language
- Indicaxanthin stimulated or inhibited MPO chlorination at neutral pH depending on concentration; at pH 5 only inhibition was observed.
- primary_references
- Mechanism of interaction of betanin and indicaxanthin with human myeloperoxidase and hypochlorous acid. (2005). https://pubmed.ncbi.nlm.nih.gov/15913556/ DOI: 10.1016/j.bbrc.2005.05.031
- route
- In vitro reagent addition
- tissue
- MPO redox cycle and HOCl solution
Betalains: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 177–185
Original AI-assisted curation of twelve primary research papers; study-specific PubMed/DOI links and limitations retained. Not publisher full text. · supports · Purified human myeloperoxidase; cell-free chemistry · source_derived_draft · unverified_draft
## betalains-indicaxanthin-chlorination Indicaxanthin stimulated or inhibited MPO chlorination at neutral pH depending on concentration; at pH 5 only inhibition was observed. Model/species: Purified human myeloperoxidase; cell-free chemistry Tissue: MPO redox cycle and HOCl solution Exposure: Micromolar substrates; concentration-dependent chlorination assays Route: In vitro reagent addition Duration: Rapid kinetic measurements at 25 degrees C; pH 7.0 and pH 5.0 Limits: MPO substrates can stimulate or inhibit chlorination depending on conditions; not a universal MPO inhibitor. Primary reference: Mechanism of interaction of betanin and indicaxanthin with human myeloperoxidase and hypochlorous acid. (2005). https://pubmed.ncbi.nlm.nih.gov/15913556/ DOI: 10.1016/j.bbrc.2005.05.031
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.